4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0000950170-25-004921
Options or other derivatives
- General Counsel, Corporate Sec acquired 215,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Smith Bryan E. · General Counsel, Corporate Sec
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-10 | Grant or award : show line 1 in the form Stock Option (right to buy) | +150,500 | 150,500 | D |
| 2025-01-10 | Grant or award : show line 2 in the form Restricted Stock Units | +64,500 | 64,500 | D |
Loading xslF345X05/ownership.xml…